Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients.
Mewes JC, Steuten LM, Duijts SF, Oldenburg HS, van Beurden M, Stuiver MM, Hunter MS, Kieffer JM, van Harten WH, Aaronson NK. Mewes JC, et al. Among authors: van harten wh, van beurden m. J Cancer Surviv. 2015 Mar;9(1):126-35. doi: 10.1007/s11764-014-0396-9. Epub 2014 Sep 2. J Cancer Surviv. 2015. PMID: 25179578
Clinical outcomes of pelvic exenteration for gynecologic malignancies.
Moolenaar LR, van Rangelrooij LE, van Poelgeest MIE, van Beurden M, van Driel WJ, van Lonkhuijzen LRCW, Mom CH, Zaal A. Moolenaar LR, et al. Among authors: van lonkhuijzen lrcw, van poelgeest mie, van rangelrooij le, van beurden m, van driel wj. Gynecol Oncol. 2023 Apr;171:114-120. doi: 10.1016/j.ygyno.2023.02.010. Epub 2023 Mar 2. Gynecol Oncol. 2023. PMID: 36870097 Free article.
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study.
Terra L, Lee Meeuw Kjoe PR, Agelink van Rentergem JA, Beekman MJ, Heemskerk-Gerritsen BAM, van Beurden M, Roeters van Lennep JE, van Doorn HC, de Hullu JA, Mourits MJE, van Dorst EBL, Mom CH, Slangen BFM, Gaarenstroom KN, van der Kolk LE, Collée JM, Wevers MR, Ausems MGEM, van Engelen K, van de Beek I, Berger LPV, van Asperen CJ, Gomez Garcia EB, Maas AHEM, Hooning MJ, van der Wall E, van Leeuwen FE, Schagen SB. Terra L, et al. Among authors: van asperen cj, van dorst ebl, van der wall e, van engelen k, van doorn hc, van leeuwen fe, van beurden m, van der kolk le, van de beek i. BJOG. 2023 Jul;130(8):968-977. doi: 10.1111/1471-0528.17415. Epub 2023 Feb 19. BJOG. 2023. PMID: 36715559
Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, Massuger LF, Gaarenstroom KN, Mourits MJ, Verheijen RH, van Dorst EB, van der Putten H, van der Velden K, Boonstra H, Aaronson NK. Madalinska JB, et al. Among authors: van dorst eb, van der putten h, van der velden k, van beurden m. J Clin Oncol. 2005 Oct 1;23(28):6890-8. doi: 10.1200/JCO.2005.02.626. Epub 2005 Aug 29. J Clin Oncol. 2005. PMID: 16129845 Free article.
The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Madalinska JB, van Beurden M, Bleiker EM, Valdimarsdottir HB, Hollenstein J, Massuger LF, Gaarenstroom KN, Mourits MJ, Verheijen RH, van Dorst EB, van der Putten H, van der Velden K, Boonstra H, Aaronson NK. Madalinska JB, et al. Among authors: van dorst eb, van der putten h, van der velden k, van beurden m. J Clin Oncol. 2006 Aug 1;24(22):3576-82. doi: 10.1200/JCO.2005.05.1896. J Clin Oncol. 2006. PMID: 16877724 Free article.
Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
Madalinska JB, van Beurden M, Bleiker EM, Valdimarsdottir HB, Lubsen-Brandsma L, Massuger LF, Mourits MJ, Gaarenstroom KN, van Dorst EB, van der Putten H, Boonstra H, Aaronson NK. Madalinska JB, et al. Among authors: van dorst eb, van der putten h, van beurden m. J Clin Oncol. 2007 Jan 20;25(3):301-7. doi: 10.1200/JCO.2006.07.4922. J Clin Oncol. 2007. PMID: 17235045
Treatment of vulvar intraepithelial neoplasia with topical imiquimod.
van Seters M, van Beurden M, ten Kate FJ, Beckmann I, Ewing PC, Eijkemans MJ, Kagie MJ, Meijer CJ, Aaronson NK, Kleinjan A, Heijmans-Antonissen C, Zijlstra FJ, Burger MP, Helmerhorst TJ. van Seters M, et al. Among authors: van beurden m. N Engl J Med. 2008 Apr 3;358(14):1465-73. doi: 10.1056/NEJMoa072685. N Engl J Med. 2008. PMID: 18385498 Free article. Clinical Trial.
Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial.
Terlou A, van Seters M, Ewing PC, Aaronson NK, Gundy CM, Heijmans-Antonissen C, Quint WG, Blok LJ, van Beurden M, Helmerhorst TJ. Terlou A, et al. Among authors: van seters m, van beurden m. Gynecol Oncol. 2011 Apr;121(1):157-62. doi: 10.1016/j.ygyno.2010.12.340. Epub 2011 Jan 15. Gynecol Oncol. 2011. PMID: 21239049 Free article. Clinical Trial.
138 results